Allotment of ~38.72 lakh equity shares at Rs.40 each on a share-swap basis
Arvaya Healthcare Ltd has allotted ~38.72 lakh fully paid-up equity shares of face value Rs.10/- each at an issue price of Rs.40/- per share, including a premium of Rs.30/- per share, aggregating to ~Rs.
By ScoutQuest · · 2 min read
- Shares Allotted
- ~38.72 lakh fully paid-up equity shares of face value Rs.10/- each
- Issue Price
- Rs.40/- per share, including a premium of Rs.30/- per share, aggregating to ~Rs. 15.49 crore
- Paid-up Capital
- rises from ~Rs. 48.02 crore to ~Rs. 51.89 crore, now comprising ~5.19 crore equity shares
What the board approved
The board of Arvaya Healthcare Ltd (formerly Bijoy Hans Ltd), at its meeting held on Saturday, October 24, 2026, approved the allotment of ~38.72 lakh fully paid-up equity shares of face value Rs. 10/- each, at an issue price of Rs. 40/- per equity share including a premium of Rs. 30/- per equity share, aggregating to ~Rs. 15.49 crore.
Who receives the shares
- The shares are allotted on a preferential basis through a private placement to the shareholders of Sushodha Institute of Gastroenterology Private Limited (SIGPL).
- The consideration is other than cash, on a share swap basis.
- The list of allottees is set out in Annexure A to the update.
Share capital after the allotment
- Paid-up equity capital rises from ~Rs. 48.02 crore to ~Rs. 51.89 crore.
- The company now has ~5.19 crore equity shares of Rs.10/- each.
- The new equity shares rank pari-passu with the existing equity shares in all respects.
Lock-in and listing
- The equity shares allotted on a preferential basis are locked-in for a specified period in compliance with Chapter VII of the ICDR Regulations, 2018.
- The company will make an application to the stock exchanges for listing and trading approval of the newly allotted shares.
Approvals received earlier
- The issue was considered at the board meeting held on Saturday, July 11, 2026.
- Shareholders gave approval through postal ballot dated 13th August 2026.
- In-principle approval was received from BSE Ltd vide letter dated October 12, 2026.
What it means for a retail holder
The announcement records a completed allotment of new equity shares to a set of incoming shareholders, paid for with a share swap rather than cash. The equity share count of the company increases by the number of shares allotted, and the new shares will be eligible for listing and trading only after exchange approval.
Also from Arvaya Healthcare
Executive Director allotted ~5.91 lakh equity shares on preferential basis
24 Oct 2026
Board approves allotment of ~38.72 lakh equity shares at Rs.40 on a share swap basis
24 Oct 2026
Board meeting on 24 October 2026 to consider allotment of ~38.72 lakh equity shares to SIGPL shareholders
17 Oct 2026
More numbers
- Equity shares allotted38,71,854
- Face value per equity shareRs.10/-
- Issue price per equity shareRs.40/-
- Premium per equity shareRs.30/-
- Total allotment amountRs. 15,48,74,160/-
- Paid-up equity capital before allotmentRs. 48,02,18,570/-
- Paid-up equity capital after allotmentRs. 51,89,37,110/-
- Equity shares outstanding after allotment5,18,93,711
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.